We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available in our Cookie and Privacy Policy.
Accept Cookies

Precision Body Composition

BODYCOMP™ ANALYSIS

Precision Body Composition Decision Support in One Scan

SOZO with Bioimpedance Spectroscopy (BIS) offers non-invasive precision in tracking fat mass, lean mass and fluid status, all in under 30 seconds:

  • Track muscle preservation for weight management patients
  • Track fat loss
  • Monitor muscle mass in GLP-1 patients
  • Designed for clinical workflow: fast, intuitive, and repeatable
  • FDA-cleared for use with healthy & unhealthy patient populations

Supporting Clinical Impact of
Treatment Plans

Personalized Exercise

Informs personalized exercise and medical weight management plans.

Metabolic Risks

Identifies metabolic risks early, including weight gain from endocrine therapy or loss of lean mass from inactivity.

Nutrition

Validates fluid, fat mass, and muscle response to nutritional plans.

CASE STUDY

Seeing What Traditional Monitoring with the Scale Missed During 6-month Weight Loss

Patient History

This 59-year-old female with Class I Obesity and CAD was monitored with SOZO BodyComp prior to and during initiation of GLP-1/GIP therapy for weight loss.

What the Clinician Saw

  1. Steady weight loss of approximately 0.8 lbs / 0.36 kg per week correlated with decrease in BMI.
  2. Noticed steady increase in Skeletal Muscle Mass (SMM) % and decrease in Fat Mass (FM) % through first 3 months but at months 4 and 5 saw a decrease in SMM and increase in FM.
  3. SMM stabilized over the next month then began to increase with intervention by month 6, while at the same time, FM began to decrease again.

Outcomes

  • Weight decreased from 188.2 lbs / 85.4 kg to 166 lbs / 75.3 kg
  • Skeletal Muscle Mass preserved over 6 month weight loss

Screen with clinical data

CLINICAL PRACTICE GUIDELINES

Clinical Guidelines Support Body Composition Monitoring for Weight Management

The Lancet Diabetes & Endocrinology Commission2

  • Traditional measures of obesity, such as BMI, should only be used as a surrogate measure of health risk at a population level.
  • Clinical Assessment of Obesity requires confirmation by objective measurements, which can include direct body fat measurement by bioimpedance.

The Obesity Society, in collaboration with the Obesity Medicine Association, American Society for Nutrition (ASN), and American College of Lifestyle Medicine (ACLM)3

  • Baseline and serial assessment of lean body mass during weight loss pharmacotherapy.
  • Use of validated tools—such as bioimpedance—to monitor changes in fat mass and lean mass.4

The American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP®)

Standard 6.4 Obesity Medicine Data Collection: Required Variables states that accredited programs must capture patient variables for data collection and outcomes monitoring for obesity medicine patients, which includes body fat percentage at initial presentation and change over time.5
Contact us to schedule a BodyComp Analysis Demo
Contact Us

References

  1. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity, May 2025
  2. Rubino, Francesco et al. Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology, Volume 13, Issue 3, 221 – 26
  3. Mozzafarian et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. The American Journal of Clinical Nutrition Volume 122, Issue 1, July 2025, Pages 344-36
  4. The Obesity Society Applauds the Work of The Lancet Diabetes & Endocrinology Commission on Diagnostic Criteria of Clinical Obesity. The Obesity Society. January 2025
  5. Optimal Resources for Metabolic and Bariatric Surgery. American College of Surgeons, 2022.